Objective: The p40 subunit of interleukin (IL)-12 was recently demonst
rated in active lesions in MS. We tested whether the p40 subunit of IL
-12 can also be detected in CSF and serum of patients with this diseas
e and, if so, whether release is associated with inflammatory disease
activity. Results: This study demonstrates an increased (up to 1,000-f
old) compartmentalized release of the p40 subunit but not of the heter
odimer p70 in MS. Release of IL-12p40 correlated with classic markers
of CNS inflammation (CSF cell counts, immunoglobulin G index) and was
significantly increased in patients with gadolinium-enhancing plaques
on MRI. Moreover, release of IL-12p40 was associated with CSF levels o
f myelin basic protein as a measure of myelin degradation, Conclusion:
These results suggest a role of IL-12p40 in the pathophysiology of MS
.